Cite
HARVARD Citation
Siu, L. et al. (2020). Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors. Journal for immunotherapy of cancer. 8 (2), p. . [Online].